Richard Ginn - May 12, 2022 Form 4 Insider Report for Tenon Medical, Inc. (TNON)

Role
Chief Technology Officer, Director
Signature
/s/ Richard Ginn
Stock symbol
TNON
Transactions as of
May 12, 2022
Transactions value $
$0
Form type
4
Date filed
5/16/2022, 05:30 PM
Previous filing
Apr 26, 2022
Next filing
May 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TNON Restricted Stock Unit 451K May 12, 2022 COMMON STOCK 451K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Richard Ginn is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 These units are on a 3 year vesting schedule, for the first year they vest on an annual basis and thereafter they vest on a semi-annual basis.
F2 N/A